Vital Signs - Integrated Systems for Health Informatics and Population Management

Regular Price: USD 450

Special Price USD 383

15% OFF

* Required Fields

Regular Price: USD 450

Special Price USD 383

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on August 31, 2013, explores the needs of an ever-expanding healthcare IT and interactive domain in a patient-centric model and identifies the criteria for true intelligent systems that are defining new approaches to care, facilitating the gathering and array of health information, including population management analytics that ultimately integrate with healthcare finance protocols to support rational decision-making for cost containment.

Additionally, a company spotlight is provided for GenomeDx Biosciences in Vancouver, BC. The company has developed the Decipher Prostate Cancer Classifier test to predict the metastatic risk for patients that have undergone a prostatectomy as treatment or the surgical removal of the prostate gland.

Table of Contents

Vital Signs - Integrated Systems for Health Informatics and Population ManagementVital Signs: August 31 2013This week's issue




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.